İstanbul Menkul Kıymetler Borsası (IMKB) and NYSE Liffe, the European derivatives business of NYSE Euronext, today announced the launch of futures and options contracts based on some of the constituents of the IMKB 30 Index. The new contracts will be available for trading before the end of this year on IMKB and in the first quarter of 2013 on NYSE Liffe London market.
Standard Individual Equity Option Contracts on some of the constituents of the IMKB 30 Index will be available to trade on IMKB and on NYSE Liffe’s London central order book. NYSE Liffe will also make available, via Bclear, flexible Universal Stock Futures and standard and flexible Individual Equity Option Contracts based on some of the constituents of the IMKB 30 Index. In addition, the exchanges will also list derivatives on Turkey’s leading index the IMKB 30 Index in due course.
Roland Bellegarde, Executive Vice President for European Listing Business and Cash Tradingat NYSE Euronext said: “The introduction of these new futures and options on underlying stocks from Turkey and derivatives on the IMKB 30 index is the outcome of successful discussions between IMKB and NYSE Euronext and highlights our commitment to working collaboratively with IMKB and meeting the needs of our customers in rapidly evolving markets.”
İbrahim M. Turhan, Chairman and CEO of İMKB said: “IMKB has recently engaged in comprehensive projects to increase the volumes as well as the diversity of traded products for our investors. One of these projects is the further development of the derivatives market, that will bring significant added-value to the Turkish Capital Markets. This agreement with NYSE Liffe is just another building block to bolster the drive to promote İstanbul as a financial center. We greatly value the global experience of NYSE Euronext in the exchange industry and hope to continue our collaboration in further projects.
